These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11939133)

  • 1. Pharmacogenetics research network and knowledge base: 1st annual scientific meeting.
    Davis A; Long R
    Pharmacogenomics; 2001 Aug; 2(3):285-9. PubMed ID: 11939133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The education potential of the pharmacogenetics and pharmacogenomics knowledge base (PharmGKB).
    Owen RP; Klein TE; Altman RB
    Clin Pharmacol Ther; 2007 Oct; 82(4):472-5. PubMed ID: 17713470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics.
    Owen RP; Altman RB; Klein TE
    Hum Mutat; 2008 Apr; 29(4):456-60. PubMed ID: 18330919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PharmGKB: the pharmacogenetics and pharmacogenomics knowledge base.
    Thorn CF; Klein TE; Altman RB
    Methods Mol Biol; 2005; 311():179-91. PubMed ID: 16100408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A resource to acquire and summarize pharmacogenetics knowledge in the literature.
    Rubin DL; Carrillo M; Woon M; Conroy J; Klein TE; Altman RB
    Stud Health Technol Inform; 2004; 107(Pt 2):793-7. PubMed ID: 15360921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge.
    Hodge AE; Altman RB; Klein TE
    Clin Pharmacol Ther; 2007 Jan; 81(1):21-4. PubMed ID: 17185992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PharmGKB: the Pharmacogenetics Knowledge Base.
    Hewett M; Oliver DE; Rubin DL; Easton KL; Stuart JM; Altman RB; Klein TE
    Nucleic Acids Res; 2002 Jan; 30(1):163-5. PubMed ID: 11752281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ontology development for a pharmacogenetics knowledge base.
    Oliver DE; Rubin DL; Stuart JM; Hewett M; Klein TE; Altman RB
    Pac Symp Biocomput; 2002; ():65-76. PubMed ID: 11928517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Planning for a national effort to enable and accelerate discoveries in pharmacogenetics: the NIH Pharmacogenetics Research Network.
    Long RM
    Clin Pharmacol Ther; 2007 Mar; 81(3):450-4. PubMed ID: 17339874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family consent and the pursuit of better medicines through genetic research.
    Renegar G; Rieser P; Manasco P
    J Contin Educ Health Prof; 2001; 21(4):265-70. PubMed ID: 11803771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics Research Network and Knowledge Base third scientific meeting.
    Davis AF; Long RM
    Pharmacogenetics; 2003 Jul; 13(7):437-40. PubMed ID: 12835619
    [No Abstract]   [Full Text] [Related]  

  • 12. Systems toxicology and the Chemical Effects in Biological Systems (CEBS) knowledge base.
    Waters M; Boorman G; Bushel P; Cunningham M; Irwin R; Merrick A; Olden K; Paules R; Selkirk J; Stasiewicz S; Weis B; Van Houten B; Walker N; Tennant R
    EHP Toxicogenomics; 2003 Jan; 111(1T):15-28. PubMed ID: 12735106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Harvard case of Xu Xiping: exploitation of the people, scientific advance, or genetic theft?
    Sleeboom M
    New Genet Soc; 2005 Apr; 24(1):57-78. PubMed ID: 16552917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later.
    Relling MV; Klein TE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Caudle KE
    Clin Pharmacol Ther; 2020 Jan; 107(1):171-175. PubMed ID: 31562822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global gene mining and the pharmaceutical industry.
    Knudsen LE
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):679-83. PubMed ID: 15979678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hub for bench-to-bedside pharmacogenomic-based research.
    Voora D; Ginsburg GS
    Pharmacogenomics; 2011 Aug; 12(8):1095-8. PubMed ID: 21843063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacogenetics research network: from SNP discovery to clinical drug response.
    Giacomini KM; Brett CM; Altman RB; Benowitz NL; Dolan ME; Flockhart DA; Johnson JA; Hayes DF; Klein T; Krauss RM; Kroetz DL; McLeod HL; Nguyen AT; Ratain MJ; Relling MV; Reus V; Roden DM; Schaefer CA; Shuldiner AR; Skaar T; Tantisira K; Tyndale RF; Wang L; Weinshilboum RM; Weiss ST; Zineh I;
    Clin Pharmacol Ther; 2007 Mar; 81(3):328-45. PubMed ID: 17339863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PharmGKB: the Pharmacogenomics Knowledge Base.
    Thorn CF; Klein TE; Altman RB
    Methods Mol Biol; 2013; 1015():311-20. PubMed ID: 23824865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PharmGKB, an Integrated Resource of Pharmacogenomic Knowledge.
    Gong L; Whirl-Carrillo M; Klein TE
    Curr Protoc; 2021 Aug; 1(8):e226. PubMed ID: 34387941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.